Warfarin and epistaxis: Should warfarin always be discontinued?

Clinical Otolaryngology and Allied Sciences

Volumn 22, Issue 6, 1997, Pages 542-544

  Srinivasan, V ^a,b   Patel, H ^a   John, D G ^a   Worsley, A ^a  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Anticoagulation; Epistaxis; Warfarin

Indexed keywords

WARFARIN;

AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EPISTAXIS; FEMALE; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL;

AGED; ANTICOAGULANTS; EPISTAXIS; FEMALE; HUMANS; LENGTH OF STAY; MALE; PROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 0031404129     PISSN: 03077772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. SMALL M., MURRAY J.S.M. & MARAN A.G.D. (1982) A study of patients with epistaxis requiring admission to hospital. Health Bull. 40, 20-29
2. DENHOLM S.W., MAYNARD C.A. & WATSON H.G. (1993) Warfarin and epistaxis a case controlled study. J. Laryngol. Otol. 107, 195-196
3. CANNEGIETER S.C., ROSENDAAL F.R. & BRIET E. (1994) Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 89, 635-641
4. COULSHED D.S., FITZPATRICK M.A. & LEE C.H. (1995) Drug treatment associated with heart valve replacement. Drugs 49(6), 897-911
5. KATHOLI R.E., NOLAN S.P. & MCGUIER L.B. (1976) Living with prosthetic heart valves: subsequent non-cardiac operations and the risk of thromboembolism or haemorrhage. Am. Heart J. 92, 162-167
6. WATSON M.G. & SHENOI P.M. (1990) Drug induced epistaxis? J. Royal Soc. Med. 83, 162-164
7. KOTECHA B., FOWLER S., HARKNESS P. et al. (1996) Management of epistaxis: a national survey. Ann. Royal Coll. Surg. Eng. 78, 444-446